HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tian-Lu Wang Selected Research

Therapeutics

4/2020Treatment patterns and survival after 18F-fluorodeoxyglucose positron emission tomography/computed tomography-guided local consolidation therapy for oligometastatic non-small cell lung cancer: a two-center propensity score-matched analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tian-Lu Wang Research Topics

Disease

4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
2Neoplasms (Cancer)
06/2019 - 02/2017
1Neoplasm Metastasis (Metastasis)
04/2020
1Klatskin Tumor
06/2019
1Jaundice (Icterus)
06/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Lung Neoplasms (Lung Cancer)
02/2017
1Weight Loss (Weight Reduction)
02/2017

Drug/Important Bio-Agent (IBA)

3Dual Specificity Phosphatase 6IBA
01/2018 - 01/2016
1GemcitabineFDA Link
06/2019
1Cisplatin (Platino)FDA LinkGeneric
06/2019
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2017

Therapy/Procedure

3Radiotherapy
01/2022 - 02/2017
2Chemoradiotherapy
02/2017 - 01/2016
1Therapeutics
04/2020
1Stents
06/2019